skip to content

Contract Wins and Joint Ventures

Abzena inks ThioBridge licensing deal

31 January 2017 13:09

Abzena has announced that it has signed a licensing deal with a US biopharmaceutical company for the use of its ThioBridge technology.

This deal has a potential value exceeding $300m and has significantly boosted market confidence in the company.

At 1:09pm: (LON:ABZA) Abzena Plc share price was +0.75p at 40.5p

Story provided by

Related Company: ABZA

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.